Global Piriformis Syndrome Market Research Report 2023

Piriformis syndrome is a rare neuromuscular condition that is caused when the piriformis muscle compresses the sciatic nerve. The piriformis muscle is a flat, band-like muscle located in the buttock near the upper region of the hip joint. Piriformis syndrome mostly occurs in adults and can affect individuals from any field and activity levels. The common causes of piriformis syndrome are considered to be trauma, spasms, and overuse injury. Additionally, according to the National Center for Biotechnology Information (NCBI), the piriformis syndrome is more prevalent in patients with pain in the lower back.

The global Piriformis Syndrome market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The North American region is anticipated to dominate the market due to the existing well-established healthcare system, increasing healthcare expenditure, growing awareness about the syndrome, and rising geriatric population.

This report aims to provide a comprehensive presentation of the global market for Piriformis Syndrome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Piriformis Syndrome.

The Piriformis Syndrome market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Piriformis Syndrome market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Piriformis Syndrome companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Piriformis Syndrome Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Medication

1.2.3 Physical Therapy

1.2.4 Others

1.3 Market by Application

1.3.1 Global Piriformis Syndrome Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Piriformis Syndrome Market Perspective (2018-2029)

2.2 Piriformis Syndrome Growth Trends by Region

2.2.1 Global Piriformis Syndrome Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Piriformis Syndrome Historic Market Size by Region (2018-2023)

2.2.3 Piriformis Syndrome Forecasted Market Size by Region (2024-2029)

2.3 Piriformis Syndrome Market Dynamics

2.3.1 Piriformis Syndrome Industry Trends

2.3.2 Piriformis Syndrome Market Drivers

2.3.3 Piriformis Syndrome Market Challenges

2.3.4 Piriformis Syndrome Market Restraints

3.1 Global Top Piriformis Syndrome Players by Revenue

3.1.1 Global Top Piriformis Syndrome Players by Revenue (2018-2023)

3.1.2 Global Piriformis Syndrome Revenue Market Share by Players (2018-2023)

3.2 Global Piriformis Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Piriformis Syndrome Revenue

3.4 Global Piriformis Syndrome Market Concentration Ratio

3.4.1 Global Piriformis Syndrome Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Piriformis Syndrome Revenue in 2022

3.5 Piriformis Syndrome Key Players Head office and Area Served

3.6 Key Players Piriformis Syndrome Product Solution and Service

3.7 Date of Enter into Piriformis Syndrome Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Piriformis Syndrome Historic Market Size by Type (2018-2023)

4.2 Global Piriformis Syndrome Forecasted Market Size by Type (2024-2029)

5.1 Global Piriformis Syndrome Historic Market Size by Application (2018-2023)

5.2 Global Piriformis Syndrome Forecasted Market Size by Application (2024-2029)

6.1 North America Piriformis Syndrome Market Size (2018-2029)

6.2 North America Piriformis Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Piriformis Syndrome Market Size by Country (2018-2023)

6.4 North America Piriformis Syndrome Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Piriformis Syndrome Market Size (2018-2029)

7.2 Europe Piriformis Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Piriformis Syndrome Market Size by Country (2018-2023)

7.4 Europe Piriformis Syndrome Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Piriformis Syndrome Market Size (2018-2029)

8.2 Asia-Pacific Piriformis Syndrome Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Piriformis Syndrome Market Size by Region (2018-2023)

8.4 Asia-Pacific Piriformis Syndrome Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Piriformis Syndrome Market Size (2018-2029)

9.2 Latin America Piriformis Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Piriformis Syndrome Market Size by Country (2018-2023)

9.4 Latin America Piriformis Syndrome Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Piriformis Syndrome Market Size (2018-2029)

10.2 Middle East & Africa Piriformis Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Piriformis Syndrome Market Size by Country (2018-2023)

10.4 Middle East & Africa Piriformis Syndrome Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Novartis

11.1.1 Novartis Company Detail

11.1.2 Novartis Business Overview

11.1.3 Novartis Piriformis Syndrome Introduction

11.1.4 Novartis Revenue in Piriformis Syndrome Business (2018-2023)

11.1.5 Novartis Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Detail

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Piriformis Syndrome Introduction

11.2.4 Sanofi Revenue in Piriformis Syndrome Business (2018-2023)

11.2.5 Sanofi Recent Development

11.3 Bayer

11.3.1 Bayer Company Detail

11.3.2 Bayer Business Overview

11.3.3 Bayer Piriformis Syndrome Introduction

11.3.4 Bayer Revenue in Piriformis Syndrome Business (2018-2023)

11.3.5 Bayer Recent Development

11.4 AstraZeneca

11.4.1 AstraZeneca Company Detail

11.4.2 AstraZeneca Business Overview

11.4.3 AstraZeneca Piriformis Syndrome Introduction

11.4.4 AstraZeneca Revenue in Piriformis Syndrome Business (2018-2023)

11.4.5 AstraZeneca Recent Development

11.5 Teva Pharmaceuticals

11.5.1 Teva Pharmaceuticals Company Detail

11.5.2 Teva Pharmaceuticals Business Overview

11.5.3 Teva Pharmaceuticals Piriformis Syndrome Introduction

11.5.4 Teva Pharmaceuticals Revenue in Piriformis Syndrome Business (2018-2023)

11.5.5 Teva Pharmaceuticals Recent Development

11.6 Endo Pharmaceuticals

11.6.1 Endo Pharmaceuticals Company Detail

11.6.2 Endo Pharmaceuticals Business Overview

11.6.3 Endo Pharmaceuticals Piriformis Syndrome Introduction

11.6.4 Endo Pharmaceuticals Revenue in Piriformis Syndrome Business (2018-2023)

11.6.5 Endo Pharmaceuticals Recent Development

11.7 Omron Healthcare

11.7.1 Omron Healthcare Company Detail

11.7.2 Omron Healthcare Business Overview

11.7.3 Omron Healthcare Piriformis Syndrome Introduction

11.7.4 Omron Healthcare Revenue in Piriformis Syndrome Business (2018-2023)

11.7.5 Omron Healthcare Recent Development

11.8 DePuy Synthes

11.8.1 DePuy Synthes Company Detail

11.8.2 DePuy Synthes Business Overview

11.8.3 DePuy Synthes Piriformis Syndrome Introduction

11.8.4 DePuy Synthes Revenue in Piriformis Syndrome Business (2018-2023)

11.8.5 DePuy Synthes Recent Development

11.9 Miracle Stretch

11.9.1 Miracle Stretch Company Detail

11.9.2 Miracle Stretch Business Overview

11.9.3 Miracle Stretch Piriformis Syndrome Introduction

11.9.4 Miracle Stretch Revenue in Piriformis Syndrome Business (2018-2023)

11.9.5 Miracle Stretch Recent Development

11.10 Seirin Corporation

11.10.1 Seirin Corporation Company Detail

11.10.2 Seirin Corporation Business Overview

11.10.3 Seirin Corporation Piriformis Syndrome Introduction

11.10.4 Seirin Corporation Revenue in Piriformis Syndrome Business (2018-2023)

11.10.5 Seirin Corporation Recent Development

11.11 Nidd Valley Medical

11.11.1 Nidd Valley Medical Company Detail

11.11.2 Nidd Valley Medical Business Overview

11.11.3 Nidd Valley Medical Piriformis Syndrome Introduction

11.11.4 Nidd Valley Medical Revenue in Piriformis Syndrome Business (2018-2023)

11.11.5 Nidd Valley Medical Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Piriformis Syndrome Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Medication

    Table 3. Key Players of Physical Therapy

    Table 4. Key Players of Others

    Table 5. Global Piriformis Syndrome Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Piriformis Syndrome Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Piriformis Syndrome Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Piriformis Syndrome Market Share by Region (2018-2023)

    Table 9. Global Piriformis Syndrome Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Piriformis Syndrome Market Share by Region (2024-2029)

    Table 11. Piriformis Syndrome Market Trends

    Table 12. Piriformis Syndrome Market Drivers

    Table 13. Piriformis Syndrome Market Challenges

    Table 14. Piriformis Syndrome Market Restraints

    Table 15. Global Piriformis Syndrome Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Piriformis Syndrome Market Share by Players (2018-2023)

    Table 17. Global Top Piriformis Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Piriformis Syndrome as of 2022)

    Table 18. Ranking of Global Top Piriformis Syndrome Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Piriformis Syndrome Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Piriformis Syndrome Product Solution and Service

    Table 22. Date of Enter into Piriformis Syndrome Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Piriformis Syndrome Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Piriformis Syndrome Revenue Market Share by Type (2018-2023)

    Table 26. Global Piriformis Syndrome Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Piriformis Syndrome Revenue Market Share by Type (2024-2029)

    Table 28. Global Piriformis Syndrome Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Piriformis Syndrome Revenue Market Share by Application (2018-2023)

    Table 30. Global Piriformis Syndrome Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Piriformis Syndrome Revenue Market Share by Application (2024-2029)

    Table 32. North America Piriformis Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Piriformis Syndrome Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Piriformis Syndrome Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Piriformis Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Piriformis Syndrome Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Piriformis Syndrome Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Piriformis Syndrome Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Piriformis Syndrome Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Piriformis Syndrome Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Piriformis Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Piriformis Syndrome Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Piriformis Syndrome Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Piriformis Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Piriformis Syndrome Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Piriformis Syndrome Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Novartis Company Detail

    Table 48. Novartis Business Overview

    Table 49. Novartis Piriformis Syndrome Product

    Table 50. Novartis Revenue in Piriformis Syndrome Business (2018-2023) & (US$ Million)

    Table 51. Novartis Recent Development

    Table 52. Sanofi Company Detail

    Table 53. Sanofi Business Overview

    Table 54. Sanofi Piriformis Syndrome Product

    Table 55. Sanofi Revenue in Piriformis Syndrome Business (2018-2023) & (US$ Million)

    Table 56. Sanofi Recent Development

    Table 57. Bayer Company Detail

    Table 58. Bayer Business Overview

    Table 59. Bayer Piriformis Syndrome Product

    Table 60. Bayer Revenue in Piriformis Syndrome Business (2018-2023) & (US$ Million)

    Table 61. Bayer Recent Development

    Table 62. AstraZeneca Company Detail

    Table 63. AstraZeneca Business Overview

    Table 64. AstraZeneca Piriformis Syndrome Product

    Table 65. AstraZeneca Revenue in Piriformis Syndrome Business (2018-2023) & (US$ Million)

    Table 66. AstraZeneca Recent Development

    Table 67. Teva Pharmaceuticals Company Detail

    Table 68. Teva Pharmaceuticals Business Overview

    Table 69. Teva Pharmaceuticals Piriformis Syndrome Product

    Table 70. Teva Pharmaceuticals Revenue in Piriformis Syndrome Business (2018-2023) & (US$ Million)

    Table 71. Teva Pharmaceuticals Recent Development

    Table 72. Endo Pharmaceuticals Company Detail

    Table 73. Endo Pharmaceuticals Business Overview

    Table 74. Endo Pharmaceuticals Piriformis Syndrome Product

    Table 75. Endo Pharmaceuticals Revenue in Piriformis Syndrome Business (2018-2023) & (US$ Million)

    Table 76. Endo Pharmaceuticals Recent Development

    Table 77. Omron Healthcare Company Detail

    Table 78. Omron Healthcare Business Overview

    Table 79. Omron Healthcare Piriformis Syndrome Product

    Table 80. Omron Healthcare Revenue in Piriformis Syndrome Business (2018-2023) & (US$ Million)

    Table 81. Omron Healthcare Recent Development

    Table 82. DePuy Synthes Company Detail

    Table 83. DePuy Synthes Business Overview

    Table 84. DePuy Synthes Piriformis Syndrome Product

    Table 85. DePuy Synthes Revenue in Piriformis Syndrome Business (2018-2023) & (US$ Million)

    Table 86. DePuy Synthes Recent Development

    Table 87. Miracle Stretch Company Detail

    Table 88. Miracle Stretch Business Overview

    Table 89. Miracle Stretch Piriformis Syndrome Product

    Table 90. Miracle Stretch Revenue in Piriformis Syndrome Business (2018-2023) & (US$ Million)

    Table 91. Miracle Stretch Recent Development

    Table 92. Seirin Corporation Company Detail

    Table 93. Seirin Corporation Business Overview

    Table 94. Seirin Corporation Piriformis Syndrome Product

    Table 95. Seirin Corporation Revenue in Piriformis Syndrome Business (2018-2023) & (US$ Million)

    Table 96. Seirin Corporation Recent Development

    Table 97. Nidd Valley Medical Company Detail

    Table 98. Nidd Valley Medical Business Overview

    Table 99. Nidd Valley Medical Piriformis Syndrome Product

    Table 100. Nidd Valley Medical Revenue in Piriformis Syndrome Business (2018-2023) & (US$ Million)

    Table 101. Nidd Valley Medical Recent Development

    Table 102. Research Programs/Design for This Report

    Table 103. Key Data Information from Secondary Sources

    Table 104. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Piriformis Syndrome Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Piriformis Syndrome Market Share by Type: 2022 VS 2029

    Figure 3. Medication Features

    Figure 4. Physical Therapy Features

    Figure 5. Others Features

    Figure 6. Global Piriformis Syndrome Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Piriformis Syndrome Market Share by Application: 2022 VS 2029

    Figure 8. Hospitals Case Studies

    Figure 9. Clinics Case Studies

    Figure 10. Others Case Studies

    Figure 11. Piriformis Syndrome Report Years Considered

    Figure 12. Global Piriformis Syndrome Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Piriformis Syndrome Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Piriformis Syndrome Market Share by Region: 2022 VS 2029

    Figure 15. Global Piriformis Syndrome Market Share by Players in 2022

    Figure 16. Global Top Piriformis Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Piriformis Syndrome as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Piriformis Syndrome Revenue in 2022

    Figure 18. North America Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Piriformis Syndrome Market Share by Country (2018-2029)

    Figure 20. United States Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Piriformis Syndrome Market Share by Country (2018-2029)

    Figure 24. Germany Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Piriformis Syndrome Market Share by Region (2018-2029)

    Figure 32. China Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Piriformis Syndrome Market Share by Country (2018-2029)

    Figure 40. Mexico Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Piriformis Syndrome Market Share by Country (2018-2029)

    Figure 44. Turkey Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia Piriformis Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Novartis Revenue Growth Rate in Piriformis Syndrome Business (2018-2023)

    Figure 47. Sanofi Revenue Growth Rate in Piriformis Syndrome Business (2018-2023)

    Figure 48. Bayer Revenue Growth Rate in Piriformis Syndrome Business (2018-2023)

    Figure 49. AstraZeneca Revenue Growth Rate in Piriformis Syndrome Business (2018-2023)

    Figure 50. Teva Pharmaceuticals Revenue Growth Rate in Piriformis Syndrome Business (2018-2023)

    Figure 51. Endo Pharmaceuticals Revenue Growth Rate in Piriformis Syndrome Business (2018-2023)

    Figure 52. Omron Healthcare Revenue Growth Rate in Piriformis Syndrome Business (2018-2023)

    Figure 53. DePuy Synthes Revenue Growth Rate in Piriformis Syndrome Business (2018-2023)

    Figure 54. Miracle Stretch Revenue Growth Rate in Piriformis Syndrome Business (2018-2023)

    Figure 55. Seirin Corporation Revenue Growth Rate in Piriformis Syndrome Business (2018-2023)

    Figure 56. Nidd Valley Medical Revenue Growth Rate in Piriformis Syndrome Business (2018-2023)

    Figure 57. Bottom-up and Top-down Approaches for This Report

    Figure 58. Data Triangulation

    Figure 59. Key Executives Interviewed